Latest CNBC interview (link)
- EBITDA/kg has remained the same, margins have come down due to increase in topline (due to input price increase)
- IBB has seen a 30% YOY growth in this quarter, ATBS has grown by 25-30%, butyl phenol and isobutylene have also gained market share
- Expect volume growth of 25% in FY23 (due to increased offtake of IBB and butyl phenol)
- Veeral Organics plant commissioning will take 12-15 months (capex of 250 cr.), so revenues will be only seen in FY24
- Expansion of butyl phenols and a couple of smaller niche products will require capex of 120-150 cr.
- Total capex of around 400 cr. in the next 2-years
Disclosure: Not invested